stockrowNational Research Corporation
NRC Healthcare Health Information Services
National Research Corporation’s revenue for fiscal 2025 (year ended December 2025) was $137.4 million, down 3.96% from fiscal 2024.
- Revenue
- +11.0%
- EPS
- +20.3%
- Free cash flow
- −31.4%
- Total debt
- +29.1%
Quarter to September 2026, against a year earlier
Follow NRC
Alert me
National Research Corporation (NRC) P/E ratio
As of 6 November 2026, National Research Corporation (NRC) trades at a P/E ratio of 90.2×. Over the past ten years it has ranged from 9.8× (April 2025) to 94.5× (November 2026); the current reading is higher than 100% of that period. That is above the Health Information Services industry median of 42.0× and above the Healthcare sector median of 25.2×.
P/E ratio, daily
Embed this chart
Annual newest first
| Period | P/E ratio | Change |
|---|---|---|
| FY2025 | 37.1× | 121.11% |
| FY2024 | 16.8× | (48.62%) |
| FY2023 | 32.7× | 7.51% |
| FY2022 | 30.4× | 7.68% |
| FY2021 | 28.2× | (2.22%) |
| FY2020 | 28.9× | (42.62%) |
| FY2019 | 50.3× | 56.96% |
| FY2018 | 32.1× | (17.67%) |
| FY2017 | 39.0× | 75.54% |
| FY2016 | 22.2× | 0.61% |
Quarterly newest first
| Period | P/E ratio | Change |
|---|---|---|
| Sep 2026 | 74.0× | (14.28%) |
| Jun 2026 | 86.3× | 100.86% |
| Mar 2026 | 43.0× | 15.64% |
| Dec 2025 | 37.1× | 105.00% |
| 43 more quarters | Free account |
Against its own ten years
P/E ratio against peers
| Company | P/E ratio |
|---|---|
| SOPH SOPHiA GENETICS SA compare | n/m |
| EVH Evolent Health, Inc compare | n/m |
| CARL Carlsmed, Inc. compare | n/m |
| CTEV Claritev Corporation compare | n/m |
| HSTM HealthStream, Inc. compare | 42.0× |
| GDRX GoodRx Holdings, Inc. compare | 65.7× |
| PHR Phreesia, Inc. compare | 74.4× |
| NRC National Research Corporation | 87.6× |
| OMDA Omada Health, Inc. compare | 267× |
| Health Information Services industry median | 42.0× |
| Healthcare sector median | 25.2× |
| Market median | 17.9× |
What P/E ratio is
Price to Earnings Ratio shows how much investors pay for each dollar of a company’s annual profit per share.
Stock Price ÷ EPS (Basic) (TTM)